TL;DR
- FDA sorts every closed inspection into exactly three buckets: NAI (No Action Indicated), VAI (Voluntary Action Indicated), or OAI (Official Action Indicated) — nothing else exists (FDA, Inspection classifications).
- OAI means FDA is recommending regulatory or administrative action — it's the classification that precedes a Warning Letter, not the letter itself (FDA, Inspections Database FAQ).
- A Form 483 doesn't tell you your classification. Firms sometimes get a 483 and still land VAI, and firms have gone OAI on inspections tied to no 483 at all, per the same FDA classification criteria.
- Classification is a status, not a punishment already delivered — a firm's response to inspectional observations is itself one of the factors FDA weighs before finalizing the number.
- Below: 5 steps to figure out where your last inspection landed and what to do about it before FDA tells you first.
A five-day inspection ends, the investigator packs up, and the plant manager wants one number: are we in trouble? FDA doesn't hand that number over on the spot. What the firm walks away with, at best, is a Form 483 (or nothing at all) — the classification that determines what happens next gets decided later, back at FDA, and most compliance teams never learn to read it correctly until they're staring at their first Warning Letter wondering how they got there.
That gap between "the inspection ended" and "FDA classified it" is where a lot of avoidable confusion lives. Here's how to actually read where you stand.
Step 1: Know that there are only three classifications, ever
FDA's own inspection classification page lists exactly three outcomes for any closed inspection (FDA, Inspection classifications):
- No Action Indicated (NAI) — no objectionable conditions or practices were found.
- Voluntary Action Indicated (VAI) — objectionable conditions were found, but FDA isn't prepared to recommend administrative or regulatory action; the agency expects the firm to fix things on its own.
- Official Action Indicated (OAI) — the facility is in an unacceptable state of compliance, and FDA recommends regulatory and/or administrative action.
There's no fourth category and no partial credit. Every inspection that reaches a final classification gets sorted into one of these three, full stop.
Step 2: Stop treating the Form 483 as your classification
This is the single most common misread. A Form FDA-483 lists an investigator's on-the-spot observations — it is not FDA's final word, and it is not the same thing as a classification (FDA, Inspection classifications). According to FDA's own Inspections Database FAQ, a facility usually receives no Form 483 when it lands NAI, usually does receive one when it lands VAI, and may or may not receive one when it lands OAI (FDA, Inspections Database FAQ).
Read that last part again: OAI doesn't guarantee a 483 was issued at the door, and getting a 483 doesn't guarantee you're headed for OAI. Firms that walk out with a clean-sounding exit interview and no 483 in hand sometimes still get classified OAI later, once the full inspection report and their written response are reviewed back at FDA. The 483 is a snapshot from the investigator's clipboard; the classification is a determination made afterward, with more information than the investigator had in the room.
Step 3: Understand who actually makes the classification call, and when
The investigator who ran your inspection recommends a classification, but doesn't finalize it alone. Per FDA, the agency determines the final classification by evaluating the information collected during the inspection, the investigator's classification recommendation, and additional information — including the facility's response to the observations on the 483 and its proposed or completed corrective actions (FDA, Inspection classifications).
Your classification isn't locked the moment the investigator walks out. What you submit afterward, a 483 response and evidence of corrective action already underway, is itself an input into whether FDA lands on VAI or OAI. A weak or late 483 response can be a direct factor in tipping a borderline inspection toward the more severe classification.
Step 4: Check the public database instead of guessing
FDA maintains an Inspection Classification Database, updated weekly, that publishes final classifications for most inspections once they're closed (FDA, Inspections Database FAQ). It's the same tool a competitor, an investor, or a potential customer's supplier-quality team can use to check your facility's history, or a supplier's, before signing a contract.
Two limits matter here. First, it only shows inspections that have reached a final classification; one still in internal review won't appear yet. Second, several categories are excluded entirely, including state-conducted inspections done on FDA's behalf, most pre-approval inspections, mammography facility inspections, and nonclinical lab inspections, which have their own separate GLP-compliance listing (FDA, Inspection classifications). A facility's absence from the database doesn't mean it's clean; the inspection may simply fall into an excluded category or not be finalized yet.
Step 5: Treat OAI as the fork in the road, not the end of it
OAI is the classification FDA uses when it's recommending action, and it's the population Warning Letters are generally drawn from. But OAI itself is not a Warning Letter, an import alert, or an injunction; it's the status that opens the door to any of those, depending on severity, history, and how the firm responds next. A facility that goes OAI and responds fast, with a credible root-cause investigation and evidence of implementation, is in a materially different position than one that does nothing. The classification describes where FDA thinks you stand at the point of determination, not where you're guaranteed to end up six months later.
FAQ
Does every FDA inspection get a public classification?
No. Only inspections that reach a final classification are added to the public database, and it excludes several categories entirely, including state inspections conducted on FDA's behalf, most pre-approval inspections, mammography facility inspections, and inspections of nonclinical labs, which are tracked in a separate database (FDA, Inspection classifications).
If I don't get a Form 483, does that mean I'm automatically NAI?
Not automatically, but it's the norm — FDA's own FAQ says a facility "usually" isn't issued a 483 when it lands NAI. It's a strong pattern, not a rule. Classification depends on the agency's overall evaluation, not solely on whether paperwork was handed over at the exit interview.
How long does it take for a classification to become final and appear in the database?
FDA doesn't publish a fixed universal timeline in the sources here, but the classification database is updated weekly, and it only reflects inspections that have already reached a final classification internally — so there's a lag between the inspection's last day and its appearance in the public dataset that varies by case.
Can a facility's classification change after it's issued?
The classification reflects FDA's determination for that specific inspection. A firm's subsequent corrective actions don't retroactively erase a finalized OAI from the historical record, but they directly shape what FDA does next, and they matter heavily to how the next inspection gets classified.
Why compliance teams pick Argus →
Sources: FDA, Inspection classifications, FDA, Inspections Database Frequently Asked Questions. Byline: The Argus Regulatory Analysis Team. Published 2026-07-09.